3PC-014 Metamorphine instead of polysubstance use?

Autor: R Trittler, A Abotaleb, C Böhlke, K Offner, MJ Hug, G Becker

Publikováno v: Section 3: Production and compounding.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5a6fff73e025f54cdc7c6b2578591500
https://doi.org/10.1136/ejhpharm-2023-eahp.37

3PC-029 Quality of gemcitabine ready to administer preparations

Autor: R Trittler, MJ Hug, H Reinhardt

Publikováno v: Section 3: Production and Compounding.

Background Gemcitabine ready to administer bags are frequently prepared in hospital pharmacies. Long-term stability for 84 days is published1 and dose-banding is already established at some hospitals. Little is known about the quality of different ge

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f4d099f4368eb1689ce1cebe5fe780f4
https://doi.org/10.1136/ejhpharm-2019-eahpconf.110

PP-035 Stability studies with levosimendan syringes

Autor: MJ Hug, R Trittler

Publikováno v: European Journal of Hospital Pharmacy. 21:A135.2-A135

Background Levosimendan (Simdax) is a calcium sensitizer that is effective in the treatment of heart failure. The available vials contain an adult dose but levosimendan is also used as off-label treatment in children. Aseptic preparation of low doses

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::16e3c9f22cd6fc9685aa641223ece5f1
https://doi.org/10.1136/ejhpharm-2013-000436.333

PKP-017 Monitoring of ivacaftor serum levels

Autor: R Trittler, MJ Hug

Publikováno v: European Journal of Hospital Pharmacy. 21:A143.2-A144

Background Ivacaftor (Kalydeco) is the first drug to treat the molecular defect underlying cystic fibrosis (CF). To this end the substance appears to be effective only in patients with the G551D mutation in the CFTR gene. Due to the low number of pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::275516c31445d221d755d5af7eeb2039
https://doi.org/10.1136/ejhpharm-2013-000436.352

Dysregulated mitochondrial fission and neurodegeneration proteomic signature in ACSF3-deficient cells.

Autor: Alatibi K; Pharmacy, Medical Center - University of Freiburg, 79106 Freiburg, Germany; G.E.R.N. Research Center for Tissue Replacement, Regeneration & Neogenesis, Department of Prosthetic Dentistry, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany., Sumser K; Pharmacy, Medical Center - University of Freiburg, 79106 Freiburg, Germany; G.E.R.N. Research Center for Tissue Replacement, Regeneration & Neogenesis, Department of Prosthetic Dentistry, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany., Christopoulou ME; Department of Pneumology, Medical Center - University of Freiburg, 79106 Freiburg, Germany., Hug MJ; Pharmacy, Medical Center - University of Freiburg, 79106 Freiburg, Germany., Tucci S; Pharmacy, Medical Center - University of Freiburg, 79106 Freiburg, Germany; G.E.R.N. Research Center for Tissue Replacement, Regeneration & Neogenesis, Department of Prosthetic Dentistry, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany. Electronic address: sara.tucci@uniklinik-freiburg.de.

Publikováno v: Biochimica et biophysica acta. Molecular and cell biology of lipids [Biochim Biophys Acta Mol Cell Biol Lipids] 2024 Nov 23; Vol. 1870 (2), pp. 159582. Date of Electronic Publication: 2024 Nov 23.